Pdt Partners, LLC Myriad Genetics Inc Transaction History
Pdt Partners, LLC
- $1.58 Billion
- Q2 2025
A detailed history of Pdt Partners, LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Pdt Partners, LLC holds 41,405 shares of MYGN stock, worth $249,672. This represents 0.01% of its overall portfolio holdings.
Number of Shares
41,405
Previous 96,434
57.06%
Holding current value
$249,672
Previous $855,000
74.39%
% of portfolio
0.01%
Previous 0.07%
Shares
6 transactions
Others Institutions Holding MYGN
# of Institutions
233Shares Held
93.7MCall Options Held
450KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$91.4 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$55.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$29.7 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$29 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$27.7 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $486M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...